Helen X Chen, MD
Helen X Chen, MD
Medical Oncologist
National Cancer Institute
6130 Executive Blvd., Suite 715
Bethesda,
MD
USA
20890
Papers:
136 - Scientific Plenary
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 m